SutroVax Announces $85M Series C Financing led by TPG Growth

SutroVax Announces $85M Series C Financing led by TPG Growth SutroVax Announces $85M Series C Financing led by TPG Growth Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board...
Sutro Biopharma, Inc.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.